Arbutus Biopharma ABUS reported its Q2 earnings results on Thursday, August 4, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Arbutus Biopharma beat estimated earnings by 23.08%, reporting an EPS of $-0.1 versus an estimate of $-0.13.
Revenue was up $11.91 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 0.78% drop in the share price the next day.
Here's a look at Arbutus Biopharma's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.16 | -0.19 | -0.24 | -0.22 |
| EPS Actual | -0.11 | -0.15 | -0.24 | -0.23 |
| Revenue Estimate | 4.37M | 2.87M | 2.38M | 2.12M |
| Revenue Actual | 12.58M | 3.21M | 3.34M | 2.33M |
To track all earnings releases for Arbutus Biopharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.